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Resumo 
 
 
O Síndrome de Down (DS) é a causa genética mais frequente de atraso 
mental. À semelhança de outros síndromes em que ocorrem deficiências em 
termos de memória e aprendizagem, as anomalias em especial ao nível das 
espinhas dendríticas estão também presentes. As espinhas dendríticas exibem 
rápidas mudanças em número, tamanho, forma e motilidade. Estas mudanças 
estão associadas à plasticidade sináptica e requerem a síntese de proteínas in 
situ, ou seja, translação local dendrítica. Down Syndrome Cell Adhesion 
Molecule (DSCAM) é um dos genes importantes nesta patologia neuronal 
(DS). Neste trabalho foram analisadas isoformas de DSCAM (isoformas 1, 3, 4 
e 5) originadas por poliadenilação alternativa e que contem motivos de 
regulação denominados Cytoplasmic Polyadenylation Element (CPE). Assim, a 
translação local dendrítica de algumas destas isoformas é regulada pela 
proteína CPEB. Para visualizar a expressão destas isoformas foram 
efectuadas construções com a proteína Kaede. Inicialmente esta proteína 
produz fluorescência em verde e após fotoconversão em vermelho e 
estimulação sináptica, a nova proteína sintetizada é observada novamente em 
verde. Neste trabalho foram utilizadas culturas de neurónios de hipocampo, 
transfectadas com as construções efectuadas com Kaede-DSCAM-isoforms e 
analisadas através de microscopia confocal. Aparentemente, as quatro 
isoformas de DSCAM tem distintos locais de expressão em neurónios. Kaede-
DSCAM-Isoform 1 é expressa em dendrites e axónios mas não no corpo 
celular neuronal, enquanto que Kaede-DSCAM-Isoform 3 parece ser expressa 
em todos os compartimentos neuronais. A expressão de Kaede-DSCAM-
Isoform 4 confere uma morfologia aberrante ao corpo celular neuronal no qual 
se expressa de forma intensa. Finalmente, a expressão de Kaede-DSCAM-
Isoform 5 é visualizada na forma de grânulos, em neurites semelhantes a 
axónios. Apesar da estimulação sináptica não ter sido executada neste 
trabalho, a utilização de DSCAM Kaede-reporters representa uma ferramenta 
valiosa para a visualização da translação local em culturas neuronais de 
hipocampo. A aplicação desta metodologia em neurónios de hipocampo de 
ratos trissomicos Ts1Cje, pode também levar à obtenção de conclusões de 
extrema importância no que diz respeito ao papel de DSCAM em DS. 
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Abstract 
 
Down’s syndrome (DS) is the most frequent genetic cause of mental 
retardation. Like in other syndromes involving memory and learning 
impairment, synaptic structural abnormalities are present, especially at the level 
of dendritic spines. Dendritic spines undergo rapid changes in number, size, 
shape and motility. These changes are linked to synaptic plasticity and require 
in situ protein synthesis, that is, dendritic local translation. Down Syndrome Cell 
Adhesion Molecule (DSCAM) is an important gene for DS neuronal pathology. 
DSCAM isoforms analysed in this work (isoforms 1, 3, 4 and 5) are originated 
by alternative polyadenylation and bear different combinations of regulatory 
Cytoplasmic Polyadenylation Element (CPE) motifs. Thus, dendritic local 
translation of some of these isoforms is regulated by CPEB protein. To 
visualize the local expression of these isoforms, constructions with Kaede 
protein were made. Kaede protein initially produces green fluorescence, and 
after irreversible green to red photoconversion and synaptic stimulation, newly 
synthetized proteins can be observed in green. In this work, hippocampal 
neuronal cultures were transfected with DSCAM Kaede-based reporters and 
analysed by confocal microscopy. We have found that apparently, the four 
DSCAM isoforms have distinct expression locations in neurons. Kaede-
DSCAM-isoform 1 is expressed in dendrites and axons but not in cell body 
whereas Kaede-DSCAM-isoform 3 appears to be expressed in all neuronal 
compartments. Kaede-DSCAM-isoform 4 expression seems to confer an 
aberrant morphological appearance to the neuronal cell body, where it is highly 
expressed. Finally, expression of Kaede-DSCAM-isoform 5 is visualized in form 
of granules that delineate axon-like neurites. Despite synaptic stimulation of 
neurons was not performed in this work, DSCAM Kaede-based reporters 
represent a valuable tool for visualizing DSCAM local translation in 
hippocampal neuron cultures. The application of this methodology to trisomic 
Ts1Cje mouse hippocampal neurons can also lead in the near future to 
valuable conclusions in what concerns the role of DSCAM in DS. 
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1.1 Transport and local translation of dendritic mRNAs 
The synthesis of a specific protein or functional cohort of proteins at a specific time 
and place in the cell is required for many cellular functions (Bramham and Wells, 2007). 
Neurons are morphologically complex cells. They show a high degree of structural 
polarization, represented by dendrites, axons and cell bodies that indeed define functional 
compartments (Fig. 1). These compartments are able to respond to local signals and 
regulate different cellular processes (Grafstein and Forman, 1980). Local translation of 
dendritic mRNAs is an example. A descriptive model of neuron morphology and post-
transcriptional regulation is shown in the figure 1.  
 
 
Figure 1: Complexity of neuronal morphology and post-transcriptional regulation.  
Typical neuron illustrating four gross neuronal anatomical segments: cell body/soma, axonal shaft, dendritic 
arbor, and growth cone. Inset shows a synapse, with presynaptic and post-synaptic terminals. The post-
transcriptional mechanisms highlighted here are alternative splicing (AS), RNA transport, and miRNA 
silencing. AS occurs in the nucleus of the cell body, and is important for generating protein isoforms. Following 
splicing and mRNA maturation, the transcript can be packaged into transport ribonucleoprotein particles 
(RNPs), repressed by RNA-binding proteins (RBPs) and/or miRNAs, delivered to distal sites of the neuron, 
and locally translated in response to stimuli. Moreover, miRNAs are involved in finely regulating protein levels 
throughout the cell (From Van Vactor et al 2010). 
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In a classical view, mRNA is exported to the cytosol, then it is translated by 
polyribosomes in the cell body, and the novo proteins are transported to its respective site 
of action (Van Vactor et al., 2010).  
In 1982, Steward and Levy reported for the first time the existence of polyribosome 
accumulation at the neck of dendritic spines. This observation suggested the possibility 
that translation occurred not only in the cell body, but also into dendrites (Steward and 
Levy, 1982).  
On the surface of neuronal dendrites there are small protrusions - dendritic spines 
- where synaptic sites are formed to receive presynaptic signals and transmit mainly 
excitatory signals (Kirov and Harris, 1999).  That mRNA can distribute into both neuronal 
axons and dendrites is well established. It is also assumed that the synthesis of proteins 
in the dendrites is regulated by mRNA transport to specific cellular locations (Kim et al., 
2005). However, the mechanism by which specific mRNAs are transported is still largely a 
mystery (Bramham and Wells, 2007, Dictenberg et al., 2008). 
From the moment a gene is transcribed, it undergoes a series of post 
transcriptional regulatory modifications in the nucleus and cytoplasm until its final 
deployment as a functional protein. Initially, a mRNA is subjected to extensive structural 
regulation through alternative splicing, which is capable of greatly expanding the protein 
repertoire by generating, in some cases, thousands of functionally distinct isoforms from a 
single gene locus. Then, RNA packages into neuronal transport granules as 
ribonucleoprotein particles (RNPs), stress granules (SGs) and processing bodies (PBs) 
(Anderson and Kedersha, 2006, Kiebler and Bassell, 2006).  
The recognition by RNA-binding proteins and/or microRNAs is capable of 
restricting protein synthesis to selective locations and under specific input conditions. This 
ability of the posttranscriptional apparatus to expand the informational content of a cell 
and control the deployment of proteins in both spatial and temporal dimensions is a 
feature well adapted for the extreme morphological properties of neural cells (Van Vactor 
et al., 2010). The figure 2 summarises the main known mechanism responsible for 
translation control in dendrites.  
 
Regarding the role of local translation, it is now clear that this process is important 
for dendritogenesis, axonal growth and synaptogenesis during development and for 
synaptic plasticity in the adulthood. 
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Figure 2: Translation control in dendrites.  
The illustration depicts neurotransmitter receptor-coupled pathways that have been implicated in the control of 
dendritic protein synthesis at excitatory synapses in the mammalian brain (the dotted lines represent unknown 
signaling pathways) (From Bramham & Wells 2007).  
It is widely accepted that most mRNAs are transported into dendrites as part of 
large RNPs. Although not proven, it is thought that the mRNAs are transported in a 
translationally dormant state. Therefore, in order for specific mRNAs to be dendritically 
targeted, they must first be sequestered from the translational machinery in the cytoplasm 
and organized into RNPs. The sequestration for translation is likely to start in the nucleus, 
with the binding of proteins that will remain bound to the mRNA on its journey out of the 
nucleus and into the dendrite (Bramham and Wells, 2007). Phosphorylation of eIF4E is 
considered the rate-limiting step for the translation of most mRNAs. The phosphorylation 
of this factor is correlated with enhanced rates of cap-dependent translation, whereas 
hypophosphorylation is associated with decreased translation (Klann and Dever, 2004, 
Richter and Sonenberg, 2005). Cap-dependent translation in dendrites is thought to be 
stimulated by two receptor coupled kinase pathways: extracellular signal-regulated kinase 
(ERK) signaling, which leads to phosphorylation of eIF4E, and mammalian target of 
rapamycin (mTOR) signaling, which leads to phosphorylation of eIF4E-binding protein 
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(eIF4E-BP) and release of eIF4E, which then becomes available for cap binding. Dendritic 
protein synthesis that affects synaptic plasticity is also controlled at the level of peptide 
chain elongation. eEF2 is a GTP-binding protein that mediates the translocation of 
peptidyl-tRNAs from the A-site to the P-site on the ribosome as amino acids are added to 
the peptide chain. Phosphorylation of eEF2 on Thr56 inhibits eEF2–ribosome binding and 
arrests elongation (Browne and Proud, 2002, Bramham and Wells, 2007). 
 
In addition to these general mechanisms for controlling local translation rates, 
there are specific proteins involved in regulating local translation of particular sets of 
dendritic mRNAs. The most well-known are FMRP and CPEB. 
 
1.1.1 Fragile-X Mental Retardation Protein (FMRP) 
FMRP is a selective RNA-binding protein that regulates the local translation of a 
subset of mRNAs and is likely to be involved in mRNA metabolism in many cell types 
(Bassell and Warren, 2008). A trinucleotide repeat expansion inactivating the X-linked 
FMR1 gene, leads to the absence of FMRP, associated with a form of mental retardation 
called fragile-X syndrome (FXS) (Garber et al., 2006). 
In neurons, FMRP is localized to dendrites, and the loss of FMRP results in altered 
synaptic morphology and plasticity (Bramham and Wells, 2007). The altered synaptic 
functions are a consequence of excess and dysregulated mRNA translation and loss of 
protein synthesis-dependent plasticity (Bassell and Warren, 2008).  
The regulation of mRNA translation by FMRP is a complicated and poorly defined 
process (Garber et al., 2006). Even so, and regarding recent reviews that have examined 
the current understanding of FMRP regulation and function in neurons, two proposed 
models are shown in the figure 3 and figure 4.  
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Figure 3: Postsynaptic FMRP Signaling Model.  
Following stimulation of Gp1 mGluRs (green), inactive PP2A (gray) is immediately activated (green) and 
dephosphorylates FMRP (orange), allowing rapid translation of FMRP-associated mRNAs. Within 5 min, 
mTOR (blue) is activated via a homer cascade, inhibiting PP2A and activating S6K1 (red), leading to FMRP 
phosphorylation and possible translational inhibition of FMRP target mRNAs. Simultaneously, mTOR activates 
translation in an FMRP-independent manner, triggering a sustained maintenance of translation. FMRP-
dependent and -independent pathways control AMPA receptor internalization and other changes in synaptic 
function and spine morphology that contribute to synaptic plasticity (From Bassell and Warren, 2008). 
 
 
 
 
 
 
 
 
 
 LOCAL TRANSLATION OF CANDIDATE mRNAs FOR DOWN’S SYNDROME  
8 
 
 
 
 
Figure 4: The Stimulated Travels and Function of FMRP throughout the Neuron.  
FMRP is in a complex with several translationally arrested mRNAs at the synapse. Following mGluR 
stimulation, FMRP-target mRNAs are rapidly derepressed, allowing for local translation. A second phase of 
FMRP-dependent plasticity is shown that involves the subsequent transport of new mRNAs from the cell body 
into dendrites. The model shown here illustrates translational repression at the level of elongation, as 
suggested by Ceman et al. (2003). The translational activation and repression of mRNA is regulated by a 
PP2A/S6K1 signaling module (Narayanan et al., 2007, Narayanan et al., 2008) (see Figure 3). (1) Upon 
mGluR1/5 activation, PP2A is rapidly activated and dephosphorylates FMRP, thereby allowing for (2) local 
translation of proteins that affect AMPAR trafficking, i.e., PSD-95, Arc, Map1b, and App (Hou et al., 2006, 
Westmark and Malter, 2007, Park et al., 2008, Waung et al., 2008). Following mGluR activation, FMRP is 
rephosphorylated by S6K1 with slower kinetics, leading to translational repression. (3) FMRP can also be 
ubiquitinated following mGluR stimulation, and its proteosome-dependent degradation is necessary for 
mGluR-LTD (Hou et al., 2006). The local degradation of FMRP may contribute to local protein synthesis 
underlying mGluR-LTD. A mechanism of local FMRP degradation may be balanced by its synthesis. FMRP is 
synthesized in synaptoneurosomes upon mGluR activation (Weiler et al., 1997), which may provide a 
feedback mechanism to restore translational repression. Upon mGluR stimulation, (4) there may be a 
retrograde signal that leads to the transport of new FMRP-associated mRNAs from the soma. The active 
bidirectional transport of FMRP granules in dendrites has recently been described (Dictenberg et al., 2008). 
This model speculates that FMRP itself may traffic from the synapse to the cell body and/or nucleus, where it 
may complex with new target mRNAs, and return to the activated synapse. (5) In that FMRP can shuttle into 
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the nucleus, it will be interesting to assess whether nucleocytoplasmic trafficking is regulated by mGluR 
signaling. (6) FMRP has recently been shown to be necessary for the transport of several mRNAs into 
dendrites, whereas neurons cultured from Fmr1 KO mice show impaired mRNA transport dynamics 
(Dictenberg et al., 2008). This model speculates that the trafficking population of FMRP is phosphorylated; 
however, future work is needed to assess whether FMRP phosphorylation may influence mRNA trafficking 
(From Bassell and Warren, 2008). 
 
 
 
 
 
 
1.1.2 Cytoplasmic Polyadenylation Binding Protein (CPEB) 
CPEB is a highly conserved, sequence-specific RNA binding protein. It binds to 
the cytoplasmic polyadenylation element (CPE), and modulates translational repression 
and mRNA localization (Mendez and Richter, 2001). After being found in Xenopus 
oocytes, three additional CPEB proteins containing similar RNA-binding domains were 
identified in mice, and thus called CPEB2–4 (Theis et al., 2003). It now appears that 
CPEB2–4 do not bind to the same cis-element as CPEB1 and, although they might 
regulate mRNA translation, they do not do so by regulating polyadenylation (Huang et al., 
2006). Therefore, CPEB2–4 might represent a separate class of RNA-binding proteins. A 
great deal more is known about how CPEB1 regulates translation.  
CPEB1 is present in many regions of the brain, including the hippocampus, the 
cerebellum and the cortex, where it localizes to synapses and is a component of the 
postsynaptic density (PSD) (Wu et al., 1998).  
The CPE is bound by CPEB (Fig. 5), a highly conserved zinc finger and RNA-
Recognition Motif (RRM) - type RNA-binding protein. Triggering of polyadenylation by this 
protein requires the kinase Eg2, an enzyme that is activated soon after Xenopus oocytes 
are exposed to progesterone (Anderson and Kedersha, 2006) and which seems to be 
further activated at maturation. Eg2, a member of the AURORA family of serine/threonine 
protein kinases, phosphorylates CPEB at serine residue 174 , an event that increases the 
affinity of CPEB for the cleavage and polyadenylation specificity factor (CPSF) (Mendez et 
al., 2000). 
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Figure 5: CPEB-mediated translational control.  
In immature oocytes, messenger RNAs containing a cytoplasmic polyadenylation element (CPE) are 
translationally dormant (masked) and reside in a complex containing the CPE-binding protein (CPEB), maskin 
and eIF4E. Once maturation begins, newly phosphorylated CPEB (by the kinase Eg2) recruits the cleavage 
and polyadenylation specificity factor (CPSF) and poly(A) polymerase (PAP), which elongates the poly(A) tail. 
At a time coincident with this elongation, maskin dissociates from eIF4E. One possible cause of this maskin–
eIF4E dissociation is the formation of a stable poly(A)-binding protein (PABP)–eIF4G complex, which 
outcompetes maskin for binding to eIF4E and thereby assembles the 48S complex. ORF, open reading frame 
(from Mendez and Ritcher, 2001)  
The binding of CPEB1 near the end of the 3-UTR anchors a complex of proteins 
that include an eIF4E binding protein (Maskin), a poly(A)-polymerase (Gld2), a scaffolding 
protein (Symplekin) and a deadenylase (poly(A)-specific ribonuclease (PARN)). Binding of 
CPEB1 to the mRNA initially inhibits mRNA translation through the interaction of Maskin 
and eIF4E, however, CPEB1 phosphorylation leads to the dissociation of PARN from the 
complex and subsequent polyadenylation of tail by Gld-2 (Richter and Kim, 2006). This 
polyadenylation results in the dissociation of Maskin from eIF4E and the activation of 
translation.  
CPEB1-mediated translation is activated when CPEB1 is phosphorylated at two 
crucial residues (Thr171 and Ser177 in mouse). In hippocampal neurons, both Aurora 
kinase A and αCaMKII have been implicated in the phosphorylation of this site and Aurora 
kinase A is thought to phosphorylate CPEB in cerebellar Purkinje neurons (Wells et al., 
2007). 
Furthermore, CPEB1-mediated translation can be activated following glutamate 
stimulation, and both NMDA-receptor- and mGluR-involvement have been described 
(Wells et al., 2001, Huang et al., 2002, Wells et al., 2007). Interestingly, NMDA receptor 
and mGluR appear to activate CPEB1-mediated translation of different mRNAs in 
hippocampal neurons, suggesting that CPEB1 works in concert with other regulatory 
mechanisms to control protein synthesis in dendrites.  
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1.2 Fragile X syndrome and Down’s syndrome: two forms of mental retardation 
Fragile X syndrome (FXS) is a prevalent form of inherited mental retardation (MR), 
occurring with a frequency of 1 in 4,000 males and 1 in 8,000 females. The syndrome is 
also characterized by developmental delay, hyperactivity, attention deficit disorder, and 
autistic-like behavior (Jin and Warren, 2000).  
This syndrome is caused by inactivation of FMR1, a gene identified in 1991 by 
positional cloning and named the Fragile X Mental Retardation 1 gene (Verkerk et al., 
1991). The FMR1 gene resides precisely at the cytogenetic fragile X site and was the first 
example of a trinucleotide repeat mutation. Within the 5’untranslated region of FMR1 there 
is a polymorphic CGG repeat with the most common normal length of 30 triplets. Among 
individuals with FXS, this repeat is found to be expanded beyond 200 repeats, typically 
800 repeats, and is referred to as the full mutation. Alleles with an intermediate repeat 
length (55–200 repeats) are called premutations, typically found in FXS families (Bassell 
and Warren, 2008). Therefore, the full mutation that leads to the allele silencing and 
absence of the encoded protein FMRP (Fragile X Mental Retardation Protein), results in 
FXS.  
FMRP is a protein that regulates the transport and local translation of dendritic 
mRNAs (see 1.1.1). For this reason, several evidences have been demonstrating that 
FMRP plays important roles in the adult synaptic plasticity underlying learning and 
memory. It also appears to be involved in axonal development, synapse formation, and 
the development and wiring of neuronal circuits (Gibson et al., 2008). Considering this, it 
is important to analyze local translation impairment in other mental retardation conditions. 
Down’s syndrome is the spotlight of the present work. 
Down’s syndrome (DS) is caused by trisomy of human chromosome 21 (Hsa21) 
(Hassold et al., 2007), by trisomy of the long arm of Hsa21 (chr21, 21q) or, in rare cases, 
by partial trisomy of 21q, and by the consequent increase in expression of the triplicated 
genes (Siddiqui et al., 2008). This common genetic disorder affects 1 in 700-800 live 
births and it is the most frequent genetic cause of mental retardation (Rachidi and Lopes, 
2008).  
Heart defects, early-onset Alzheimer’s disease (AD) and childhood leukemia are 
associated with the gene Hsa21 (Wiseman et al., 2009). Individuals with DS are affected 
by these deleterious phenotypes and by many others to a variable extent (Figure 6). To 
provide new insights in MR conditions, Ts65Dn and Ts1Cje mice are being valuable 
animal models were similar phenotypes can be expressed (Siddiqui et al., 2008). The 
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figure 6 shows some of the typical features of persons with segmental trisomy 21 and that 
are also present in Ts65Dn. 
 
Figure 6: Components of Down’s syndrome phenotype present in persons with segmental trisomy 21. 
The regions of trisomy in JS and KJ, indicated by the vertical bars, are quite similar to that present in the 
Ts65Dn mouse (From (Epstein, 2002))  
 
 
The additional copy of Hsa21, in people with DS, is proposed to result in the 
increased expression of many of the genes encoded on this chromosome. The imbalance 
in expression of Hsa21 and non-Hsa21 genes is hypothesized to result in the many 
phenotypes that characterize DS. However, only some of the Hsa21 genes are likely to be 
dosage-sensitive, such that the phenotype they confer is altered by gene-copy number. 
Thus to understand DS, it is crucial both to understand the genomic content of Hsa21 and 
to evaluate how the expression levels of these genes are altered by the presence of a 
third copy of Hsa21 (Wiseman et al., 2009). 
Brain morphology in DS at birth is primarily normal, but postnatal development 
slows. This results in reduced volumes of the hippocampus, cerebellum and prefrontal 
cortex, reduced neuronal densities in specific regions (including the hippocampus and 
cerebellum), and reduced dendritic branching and spine densities in the hippocampus 
(Nadel, 2003, Benavides-Piccione et al., 2004). Cognitive abilities in early infancy are 
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within the lower range of typical development, but there are decreases over the first 
decade. Resulting deficits in spatial learning tasks implicate the hippocampus; specific 
weaknesses in language skills implicate regions of the prefrontal and temporal cortices 
and the cerebellum; and additional deficits suggest impaired function of the prefrontal 
cortex (Nadel, 2003, Benavides-Piccione et al., 2004, Abbeduto et al., 2007). The 
postnatal appearance of many abnormalities argues for the potential for therapeutic 
interventions (Gardiner, 2010). 
 
 
 
1.2.1 Dendritogenesis 
Dendritic spines are the primary recipients of excitatory input in the central 
nervous system. They provide biochemical compartments that locally control the signaling 
mechanisms at individual synapses. Hippocampal spines show structural plasticity as the 
basis for the physiological changes in synaptic efficacy that underlie learning and memory. 
Spine structure is regulated by molecular mechanisms that are fine-tuned and adjusted 
accordingly to developmental age, level and direction of synaptic activity, specific brain 
region, and exact behavioral or experimental conditions. Reciprocal changes between the 
structure and function of spines impact both local and global integration of signals within 
dendrites (Bourne and Harris, 2008).  
Investigations in children and adolescents with unclassified MR have confirmed 
reduced density and spine dysgenesis involving apical dendrites of the prefrontal cortex 
(Takashima et al., 1982). In fact, impairment in dendritogenesis as well as defaults in 
dendritic spines are common to different forms of mental retardation. In Fragile X patients, 
spines are longer, thinner and more abundant than in non-affected individuals (Irwin et al., 
2001). In Down’s syndrome, dendrites are shorter, and spines are also longer and thinner 
but less abundant than in normal subjects (for a review, see (Benavides-Piccione et al., 
2004)). The figure 7 clearly shows the morphological impairment that exists in dendrites 
from retarded individuals comparing with normal ones. 
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Figure 7: Camera lucida drawings of apical dendrites of pyramidal cells from human cerebral cortex. 
A) A dendrite from a 6-month-old infant with no history of neurological disorder has a larger number of spines. 
B) Dendrite from a retarded 10-month-old child shows long and tortuous spines. C) A dendrite from a 5.5-
month-old child with severe neurobehavioral failure shows numerous varicosities and long, thin spines. D) A 
dendrite from an adult case of fragile X syndrome has a high density of elongated and enlarged spines. 
(Adapted from Harris, 2002 and (Rudelli et al., 1991)) 
 
 
1.2.2 Synaptic plasticity 
At the cellular level, long-lasting changes in synaptic strength, typically called 
synaptic plasticity, refers to the ability of neurons to alter communication with each other 
via synaptic connections in response to specific patterns of electrical stimulation and/or 
neurotrophic factors. It is generally considered to underlie long-term memory (LTM) 
(Malenka and Nicoll, 1997). Changes in gene expression are required to convert short 
term memory (STM), lasting less than 1 h, to long-term memory (LTM) in both 
invertebrates and vertebrates (Kandel, 2001).  
The most studied forms of long-lasting synaptic plasticity in mammals, particularly 
rodents, are long-term potentiation (LTP) and long term depression (LTD), which refer to 
long-lasting increases or decreases, respectively, in synaptic strength (Malenka and Bear, 
2004). Most of the work on LTP and LTD has been conducted in the hippocampus, a 
structure required for memory consolidation. 
Synaptic plasticity is considered essential for learning and storage of new 
memories. Whether all synapses on a given neuron have the same ability to express long-
term plasticity is not well understood. Synaptic microanatomy could affect the function of 
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local signalling cascades and thus differentially regulate the potential for plasticity at 
individual synapses (Holbro et al., 2009). Localization of mRNAs at the synapse has been 
proposed as a mechanism for synaptic plasticity and thus learning and memory (Klann 
and Dever, 2004).  
In addition to mRNA localization in dendrites, there are two aspects of neuronal 
plasticity important for information processing: plasticity of intrinsic excitability – that is the 
change in ion channel properties; and synaptic plasticity - that is the change in the 
strength of synapses between two neurons. Although more is known about the signaling 
pathways underlying synaptic plasticity, many of these pathways also underlie the 
plasticity of intrinsic excitability (Kotaleski and Blackwell, 2010). The figure 8 summarizes 
the key steps on synaptic plasticity.  
 
Figure 8: Succinct signaling pathways underlying synaptic plasticity. 
A) Presynaptic glutamate release and depolarization of the postsynaptic neuron leads to Ca
2+ 
elevation in the 
postsynaptic cell. Glutamate is required for activation of NMDARs (N-methyl-daspartate receptors) and 
metabotropic glutamate receptors (mGluRs), and depolarization is required for activation of NMDARs and 
voltage-dependent Ca
2+
 channels (VDCCs)(Perkel et al., 1993). The particular mechanism employed depends 
on the cell type. B) For late-phase LTP and memory storage, a combination of synaptic inputs and neuronal 
activity leads to AMPAR phosphorylation and membrane insertion, gene transcription and protein translation 
(Adapted from Kotaleski & Blackwell, 2010). 
1.2.3 Down’s Syndrome Cell Adhesion Molecule (DSCAM): a candidate gene 
DSCAM was first identified in an effort to characterize proteins located within 
human chromosome band 21q22, a region known to play a critical role in Down’s 
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Syndrome (Yamakawa et al., 1998). DSCAM promotes cation-independent homophilic 
intercellular adhesion (Agarwala et al., 2000), and none of the other genes in the 21q22 
region are known to exhibit adhesive properties (Hattori et al., 2000). The name Down’s 
Syndrome Cell Adhesion Molecule was chosen because of the chromosomal location, its 
appropriate expression in developing neural tissue, and its structure as an 
immunoglobulin (Ig) receptor related to other Cell Adhesion Molecules (CAMs). DSCAM 
proteins are one of the largest Ig superfamily CAMs discovered (220 kDa), containing 10 
Ig domains and six fibronectin type III (FN) repeats, with the tenth Ig domain located 
between FN four and five (Fig. 9) (Schmucker and Chen, 2009).  
 
Figure 9: Phylogenetic analysis of Dscam Ig receptor.  
Domain architecture of the Ig receptor Dscam is conserved over 600 million years across invertebrate and 
vertebrate species. Phylogenetic analysis of Dscam gene and protein structure indicates a presumptive origin 
of Dscam before the split of the Bilaterians. Dscam protein has nine Ig domains from N terminus, six FN 
domains, with a single Ig domain between FN domains four and five. The most notable difference between the 
arthropod and vertebrate genomic organizations is the hypervariable exon arrays in arthropods that can 
generate tens of thousands of Dscam isoforms. Alternative splicing of these exon array sequences (red, blue, 
and green) generate different sequences of the N-terminal half of Ig2 (red), the N-terminal half of Ig3 (blue), 
and the full Ig7 domain (green). Remarkably, alternative splicing of these specific hypervariable Ig domains is 
conserved between crustaceans and insects, with a common ancestor >400 million years ago. It is not known 
whether the annelid and arachnid genomes contain Dscam genes (?); the nematode genomes currently 
available do not contain Dscam (ø). (from Schmucker and Chen, 2009) 
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Since DSCAM identification, it has been suspected that elevated levels of DSCAM 
may contribute to some DS phenotypes (Yamakawa et al., 1998, Saito et al., 2000). In 
fact, because overexpression of DSCAM has been detected in DS patients (Saito et al., 
2000), it become a strong candidate involved in mental retardation conditions. 
Recently, new insights in the mouse DSCAM have been made. Five isoforms were 
isolated from neonatal (P0) and adult hippocampal mice and DSCAM expression in 
neonatal hippocampus was fourfold higher than in the adult (Alves-Sampaio et al., 2010) 
To characterize the regulation of DSCAM mRNA, functionality of the five polyadenylation 
hexamers was first assessed (Fig. 10). Moreover, DSCAM mRNA association to CPEB1 
in the mouse hippocampus and dendritic local translation in response to NMDAR activity 
were demonstrated (Alves-Sampaio et al., 2010). 
 
Figure 10: DSCAM 3’-UTR isoforms produced in mouse by alternative usage of polyadenylation 
hexamers 1–5.  
The distances between the pairs of regulatory motifs are indicated in nucleotides (n). The Pumilio-binding 
element (PBE) (in blue) is shown, including the nonconsensus and consensus cytoplasmic polyadenylation 
elements (ncCPEs and CPEs) (in white and orange, respectively), and alternative polyadenylation hexamers 
(numbered from 1 to 5; AUUAAA sequence in yellow; AAUAAA sequence in green) (Adapted from Alves-
Sampaio et al, 2010). 
DSCAM has been shown to participate in dendritic tiling and self-avoidance in the 
mouse visual system (Fuerst et al., 2008, Burgess et al., 2009), two fundamental 
phenomena related to the formation of neural circuits. DSCAM overexpression has been 
shown to inhibit dendritic arborization of mouse hippocampal neurons (Alves-Sampaio et 
al., 2010). A role of DSCAM in adult hippocampal neurogenesis has also been suggested 
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(Yamashima et al., 2007). DSCAM is strongly expressed during brain development, and 
although it is downregulated in the adult, its expression persists in brain areas with high 
levels of synaptic plasticity, including the cortex, hippocampus, and cerebellum (Agarwala 
et al., 2001, Barlow et al., 2001). Nonetheless, the function of DSCAM in the adult brain 
remains unknown. 
1.2.4 Dendritic targeting elements (DTEs) and local translation reporters  
As mentioned before, in neurons, activity-dependent mRNA targeting establishes 
certain forms of synaptic plasticity through new local protein synthesis in dendrites, and it 
is critical for proper responses to extracellular stimuli (Aakalu et al., 2001). Thus, transport 
of mRNAs to dendrites is a prerequisite for local protein synthesis. Recognition of cis-
acting elements in mRNAs by trans-acting RNA binding proteins is thought to underlie 
selective mRNA targeting. While several cis-acting dendritic targeting elements (DTEs) 
have been identified in dendritic mRNAs (Blichenberg et al., 1999, Kobayashi et al., 
2005), only a few trans-acting RNA binding proteins are known (Huang et al., 2003).  
The Cytoplasmic Polyadenylation Element (CPE), a cis element in the 3’UTRs of 
specific dendritic mRNAs, promotes cytoplasmic polyadenylation-induced translation in 
response to synaptic stimulation. It has been demonstrated that the CPE and its binding 
protein CPEB facilitate mRNA transport to dendrites (Huang et al., 2003). DSCAM 
isoforms analysed in this work (isoforms 1, 3, 4 and 5) are originated by alternative 
polyadenylation and bear different combinations of regulatory CPE motifs (Fig. 10). Thus, 
dendritic local translation of some of these isoforms is regulated by CPEB protein (Alves-
Sampaio et al., 2010).  
Fluorescent protein-based translation reporters allow the dynamically visualization 
of local synthesis of proteins in neuronal processes. The first such tools developed used a 
diffusion limited fluorescent translation reporter in which a region encoding a destabilized, 
myristoylated green fluorescent protein (GFP) is flanked by the 5’ and 3’ untranslated 
regions (UTRs) from αCaMKII mRNA (Aakalu et al., 2001), an mRNA known to be 
dendritically localized. The half-life of this destabilized GFP is >90 min, and the 
myristoylation tag has been shown to severely inhibit the free diffusion of the reporter 
once translated (Aakalu et al., 2001). This translation reporter has been used to examine 
both activity-dependent (Sutton et al., 2004) and neuromodulatory control (Aakalu et al., 
2001, Smith et al., 2005) of dendritic protein synthesis in hippocampal neurons. 
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One of the major improvements in this class of translation reporter has come from 
replacing a generic fluorescent protein with either photoconvertible fluorescent proteins 
(Kaede or Dendra) or epitope tags that bind spectrally distinct fluorescent dyes with high 
affinity (e.g., FlAsH/ReAsH). These modifications make it possible to distinguish newly 
synthesized reporter from preexisting fluorescent signal. Also, they allow for a more 
precise “dating” of new reporter signal without the need for photobleaching existing signal. 
These newer reporter systems have been used to examine local synthesis of sensorin at 
Aplysia synapses (Wang et al., 2009) and local dendritic synthesis of AMPA receptor 
subunits GluA1 and GluA2 (Ju et al., 2004) as well as Kv1.1 voltage-gated potassium 
channels (Raab-Graham et al., 2006).  
 
 
 
Figure 11: Local translation assay using photoconvertible protein Kaede.  
Schematic of local translation assay using the photoconvertible protein Kaede. Left side shows neuron with 
boxed dendrites; right side shows enlargement. Green puncta indicate local translation “hot spots.” Kaede 
initially appears green, but with UV exposure, is converted to red. New protein synthesis is monitored by the 
appearance of new green protein over time (arrowheads) (Adapted from Raab-Graham et al 2006). 
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1.3 Aim of this work 
Local translation of specific mRNAs at the synapse has been proposed as one of 
the mechanisms responsible for plasticity and thus learning and memory. FMRP and 
CPEB are two important recognized proteins involved in mRNA translation in dendrites. 
FMRP loss of function leads to Fragile X mental retardation, in which learning and 
memory are impaired. This highlights the importance of local translation for cognition. 
DSCAM belongs to the largest group of the immunoglobulin (Ig) related cell adhesion 
molecules and is involved in a number of important biological processes. This gene is 
located in the Down’s Syndrome Critical Region (DSCR), in HSA21. Interestingly, DSCAM 
is a putative FMRP-target gene (Brown et al., 2001) and its local translation is regulated 
by CPEB in hippocampal neurons (Alves-Sampaio et al., 2010). Thus, altered local 
translation of DSCAM could be responsible, at least in part, of some of the neuronal 
phenotypes associated to DS. 
In previous work, DSCAM isoforms 1, 3, 4, and 5 were amplified from mouse 
hippocampal cDNAs. Some of this isoforms were shown to be under the control of CPEB 
protein in Xenopus oocytes. However the regulation of dendritic local translation of 
DSCAM isoforms in hippocampal neurons is unknown. To provide new insights in the role 
of DSCAM isoforms, and most specifically, in the specific regulation of each DSCAM 
isoform, a photoconvertible reporter protein was chosen for visualizing and localizing the 
expression of those isoforms in transfected hippocampal neurons.  
 
The objectives of this study were: 
 
-  To modify the original Kaede plasmid, in order to use it as a reporter for 
local translation. 
 
- To visualize the expression of Kaede-DSCAM-isoform constructions in 
hippocampal neuron cultures. 
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2. Material and Methods 
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2.1 Kaede plasmid (pKaede) modification 
pKaede – MC1 ( Amalgaam, MBL, Japan) plasmid obtained at the dry form 
(20µg), was resuspended in 20µl of distilled sterile water.  To perform the vector 
linearization, 5µg of pKaede were digested with 1µl of the restriction enzyme, BamHI 
(10U) purchased from TaKaRa BIOTECH Co. (Japan).  After 4 hours at 370C, succeeded 
procedure was confirmed by electrophoresis of 1µl of digestion product through a 0.8% 
agarose gel. The subsequent 19µl of digestion product was dephosphorylated with 1µl of 
alkaline phosphatase (20U/µl) following manufacturer´s procedure. The mixture was 
incubated for 30m at 37oC. Electrophoretic separation was performed to isolate the 
linearized and dephosphorylated vector from a 0.8% agarose gel. DNA was extracted 
from the agarose using the QIAEX II Agarose Gel extraction Protocol, according to the 
manufacturer’s instructions. 
To insert a stop codon at the end of Kaede protein in pKaede-MC1 (for generating 
pKaede-3’UTR), two complementary oligos were designed that also included NheI and 
EcoRV restriction sites. These oligos named Stop-BamHI-fw and STOP-BamHI-rv were 
annealed using the precise concentrations and volumes mentioned in the table below. 
The mixture (100µl) was introduced in a bath (glass cup with water at 1000C) and 
maintained at room temperature until it decreases to 370C.  
Table 1: STOP-BamHI annealing mixture reaction composition. 
Oligos/ Buffer Concentration 
(µM, mM) 
Volume 
(µl) 
STOP-BamHI-fw,  
5´[Phos] GATCTTAATGATATCG 
 
10 µM 
 
10µl 
STOP-BamHI-rv, 
5´[Phos] GGGATCCGATATCATTAA 
 
10 µM 
 
10µl 
Buffer TrisMgCl2: 
Tris 
MgCl2 
 
62,5 mM, pH7,6 
12,5 mM 
 
80µl 
When annealed, these oligos generate BamHI-compatible ends, and this fragment 
was ligated to the pKaede vector (linearized with BamHI and dephosphorylated). We used 
3µl of pKaede, 1µl of STOP-BamHI reaction product, 5 µl of Rapid Buffer and 1µl of T4 
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DNA ligase 3U/µl (Promega). After 1h of incubation at room temperature, the final volume 
of ligation reaction (10 µl) was used to transform 50µl of Competent Cells (Subcloning 
EfficiencyTM DH5αTM, Invitrogen). The transformation method used was heat-shock: 
incubation in ice for 30 min, incubation at 370C for 20 sec followed by a 2 min incubation 
in ice. Then, 400µl of LB medium was added and this new mix was incubated for 1h at 
370C. To concentrate the transformation mix, a centrifugation at 14.000 rpm for 1 min was 
performed; 300µl of supernatant removed and the remaining 100µl of the pellet was 
spread in plates with the selective culture medium, LB with Kanamycin 50 µg/ml.  
After over-night incubation at 370C, six selected colonies were inoculated in 3,5ml 
of LB with Kanamycin 25µg/ml.  DNA of each presumable transformed colony was 
extracted and purified 24 hours later through the Pure Link Quick Plasmid Miniprep kit 
(Invitrogen), accordingly to manufacturer’s instructions. Inserted STOP oligos in pKaede 
were confirmed by restriction with EcoRV and the transformed plasmid with the correct 
orientation was selected by sequencing.  
To confirm the presence of NheI restriction site and perform the vector 
linearization for the subsequent modifications, 5µg of pKaede-3’UTR were digested with 
1µl of the restriction enzyme NheI (10U) purchased from TaKaRa BIOTECH Co. (Japan).  
After 4 hours at 370C, succeeded procedure was confirmed by electrophoresis of 1µl of 
digestion product through a 0.8% agarose gel.  The subsequent 19µl of digestion product 
was dephosphorylated with 1µl of alkaline phosphatase (20U/µl) following manufacturer´s 
procedure. The mixture was incubated for 30m at 370C. Electrophoretic separation was 
performed to isolate the linearized and dephosphorylated vector from a 0.8% agarose gel. 
DNA was extracted from the agarose using the QIAEX II Agarose Gel extraction Protocol, 
according to the manufacturer’s instructions. 
To insert a myristoylation signal at the 5’UTR of Kaede protein in pKaede-3’UTR 
(for generating p5’UTR-myrKAEDE-3’UTR), two complementary oligos were designed. 
These oligos named 5-UTR-myr-fw and 5-UTR-myr-rv were annealed using the precise 
concentrations and volumes mentioned in the table 3. The mixture (100µl) was introduced 
in a bath (glass cup with water at 1000C) and maintained at room temperature until it 
decreases to 370C.  
When annealed, these oligos generate NheI-compatible ends and contain EcoRV 
restriction site, a Kozak sequence and a myristoylation signal. This fragment was ligated 
to the 5’UTR of pKaede-3’UTR (linearized with NheI and dephosphorylated). We used 3µl 
of pKaede-3’UTR, 1µl of 5-UTR-myr reaction product, 5 µl of Rapid Buffer and 1µl of T4 
DNA ligase 3U/µl (Promega). After 1h of incubation at room temperature, the final volume 
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of ligation reaction (10 µl) was used to transform 50µl of Competent Cells (Subcloning 
EfficiencyTM DH5αTM, Invitrogen). The transformation method used here was the same 
described previously. DNA of each presumable transformed colony was extracted and 
purified 24 hours later through the Pure Link Quick Plasmid Miniprep kit (Invitrogen), 
accordingly to manufacturer’s instructions. Inserted myristoylation signal in pKaede-3’UTR 
was analysed by restriction with EcoRV and the six hypothetical p5’UTR-myrKAEDE-
3’UTR plasmids were sequenced. 
 Table 2: 5-UTR-myr annealing mixture reaction composition. 
Oligos/ Buffer  Concentration 
(µM, mM) 
Volume 
(µl) 
5-UTR-myr-fw, 
 5´[Phos]CTAGGCTAGCGATATCGCCACCATGG              
              GCACGGTGCTGTCCCTATCTCCCAGCC 
10 µM 10µl 
5-UTR-myr-rv, 
5´[Phos]CTAGGGCTGGGAGATAGGGACAGCAC 
              CGTGCCCATGGTGGCGATATCGCTAGC 
10 µM 10µl 
Buffer TrisMgCl2: 
Tris 
MgCl2 
 
62,5 mM, pH7,6 
12,5 mM 
80µl 
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2.2 Cloning of DSCAM isoforms in pKaede  
Sequences corresponding to the 3’-UTR of the DSCAM isoforms 1, 3, 4, and 5 
were originally amplified from mouse hippocampal cDNA by PCR and cloned downstream 
the Firefly luciferase coding region of the pLucCassette vector (Alves-Sampaio et al., 
2010). These vectors were used in the present work. The E.coli clones containing DSCAM 
isoforms 1, 3, 4 and 5 (DSCAM-isof1, DSCAM-isof3, DSCAM-isof4, DSCAM-isof5) stored 
at -800C, were cultured in 100ml of LB 50µg/ml ampicilin. Cultures were incubated 
overnight at 370C, 200rpm. After this period, DNA was isolated using the Pure YieldTM 
Plasmid Midiprep System (Invitrogen). The yield of total DNA was determined by 
measuring the absorbance (260-280 nm; 260-230 nm) using a NanoDrop  ND-1000 
spectrophotometer. DNA fragments containing the 3’UTR region of the corresponding 
DSCAM isoform were obtained by doubled digestion, with BamHI and BglII. Whereas both 
digestions require 4 hours of incubation at 370C, these restriction enzymes have different 
reaction buffers. For this reason, it was necessary to wash the first digestion product with 
the Sure Clean Plus kit (Bioline) before the second digestion. This is one of the several 
critical steps of the procedure were DNA can be lost. So, to obtain enough quantity of 
each DNA fragment, 15 µg of total DNA was used at the beginning of the procedure (the 
first digestion). After the second digestion with BglII a preparative electrophoresis was 
made to separate DNA fragments.  To avoid contaminations, all the electrophoretic 
material was washed with 10% SDS and the TAE (1X) renewed in the tank. To purify the 
isolated fragment from the 0,8% agarose gel, the slice of gel containing DNA was 
dissected and the QIAEX II Agarose Gel extraction kit was used, according to the 
manufacturer’s instructions.  
 
The four different inserts isolated and purified: DSCAM-isof1, DSCAM-isof3, 
DSCAM-isof4, DSCAM-isof5 were then prepared for ligation with the Kaede plasmid 
(linearized with BamHI and dephosphorylated). Ligation of the vector with the four 
different isoforms was made using the same method described in 2.1. We used 3µl of 
pKaede, 1µl of the insert, 5 µl of Rapid Buffer and 1µl of T4 DNA ligase 3U/µl. After 1h of 
incubation at room temperature, the final volume of ligation reaction (10 µl) was used to 
transform competent cells. For transformation, different competent cells were used. To 
clone DSCAM-isof1, DSCAM-isof3, DSCAM-isof5, 50 µl of DH5αTM (Subcloning 
EfficiencyTM Competent Cells, Invitrogen) was used. In the case of the plasmid containing 
DSCAM-isof4, we had to use Chemically Competent E.coli (One Shot® Mach1 TM -T1R, 
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Invitrogen). The transformation method used was heat-shock: incubation in ice for 30 min, 
incubation at 370C for 20 sec followed by a 2 min incubation in ice. Then, 400µl of LB 
medium was added to each tube and this new mix was incubated for 1h at 370C. To 
concentrate the transformation mix, a centrifugation at 14.000 rpm for 1 min was done, 
300µl of supernatant removed and the remaining 100µl of the corresponding pellet was 
spread in a plate with the selective culture medium (LB with 50 µg/ml Kanamycin). After 
over-night incubation at 370C, four colonies from each plate were inoculated in 3,5ml of LB 
with 25µg/ml of Kanamycin.  DNA of each presumable transformed colony was extracted 
and purified 24 hours later through the Pure Link Quick Plasmid Miniprep kit (Invitrogen), 
according to manufacturer’s instructions. Inserted DSCAM isoforms in pKaede were 
confirmed by restriction with EcoRI and the transformed plasmids with the sense and anti-
sense orientation were identified and selected after sequencing. 
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2.3 Hippocampal neuron cultures 
Animals were maintained, handled, and sacrificed in accordance with national and 
international laws and policies, and all protocols were approved by the University of 
Seville Animal Care and Use Committee. 
The hippocampus from postnatal day 0 (P0) wild-type mouse littermates was 
dissected out in HBSS medium (Invitrogen) and mechanically dissociated after trypsin 
treatment (0.2% trypsin for 10 min at 37°C) in DB1 culture medium (DMEM high glucose 
with L-glutamine, without sodium pyruvate; 10% fetal bovine serum; Glutamax; 08% 
glucose; penicillin/strep-tomycin).  
Cells in suspension were counted using a haemocytometer (Neubauer, Poly-labo; 
depth = 0.100mm, square surface on the grid = 0.0025 cm2) under an inverted phase 
contrast microscope (Zeiss, Germany).  
The cells (80.000 cells/well) were seeded on poly-L-lysine-treated coverslips (0.5 
mg/ml) and cultured in Neurobasal A medium (Neurobasal A; B27 supplement; Glutamax; 
penicillin/streptomycin), in 6-well plates. After 48 h in culture, 0.3 mM 5-fluoro-2-
deoxyuridine (Sigma-Aldrich) and 0.8 mM uridine (Sigma-Aldrich) were added to the 
culture medium to inhibit glial growth.  
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2.4 Cell transfection 
By definition, transfection is the introduction of a foreign DNA molecule into a 
eukaryotic cell and the subsequent expression of one or more genes in the transfected 
cell (Alberts et al., 1994). Many different chemical agents that facilitate transfection are 
commercially available. 
Two different methods were used in this work: the liposome method and the 
calcium phosphate coprecipitation method. In the liposome method, Lipofectamine 2000 
(Invitrogen) was used, following the manufacturer’s instructions, for transfection of day 7 
in vitro (DIV7) hippocampal neurons. In this method, positive charged liposomes bind to 
the negatively charged phosphates of the DNA molecules to form a complex with a 
surplus of positive charge. This positive charge is attracted to the negative charge of the 
sialic acid residues on the surface of the cell. Then the DNA-liposome complex is taken up 
by endocytosis (Farhood et al., 1994). Due to high efficiency, simplicity and versatility, this 
method was used to test the expression capacity of the reporter pKaede (CoralHue®; 
Amalgaam) compared with the constructed Kaede-3’UTR plasmid. A total of 4 µg of each 
plasmid was transfected per well. Effects on dendrite arborization were analyzed 2 days 
after transfection. Two independent experiments, using different batches of neurons, were 
performed (three transfections per experiment and plasmid). 
 
Established in the 1970’s by Graham and van der Eb (Graham and Vandereb, 
1973), the second method involves the formation of a calcium phosphate/DNA precipitate 
that sediments, attaches to the cells and is taken up by endocytosis (Chalberg et al., 
2001). For transfection of neurons with the four constructions of mouse DSCAM along 
with photoconvertible fluorescent protein Kaede (Kaede-DSCAM-isof plasmids) calcium 
phosphate method was chosen for being less toxic to cells.  
A total of 14µg/well of DNA of each DSCAM construction per well was used for 
transfection with this method. The first step consists in preparing the transfection mix, the 
calcium solution (2.5 M CaCl2 (SigmaC3881), 10μl/well) and DNA (14 μg/well, 90 µl/well) 
in individual 1.5 ml tubes (one per well). Then, the precipitate is formed by adding 2xBES 
(N, N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid) - Buffered Solution (2xBBS) 
dropwise using a vortex (Agimatic S) simultaneously for mixing the solution in the tube. 
This solution is incubated for 45 min in the dark. During this period, 1.8 ml of Neurobasal 
culture medium (GIBCO) is put in 15ml Falcon tubes and incubated at 37oC for 
temperature and pH adjustments. After this period, the mixture of DNA-CaCl2-BBS is 
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added to in prewarmed culture medium and transferred to the wells. The cover slips 
containing the DIV7 hippocampal neurons were transferred to these new plates containing 
the transfection mix and incubated for 1h30m at 370C. The plates with the original culture 
medium were stored at 370C. After this period, the transfection mix is removed and the 
cover slips are gently washed 3 times with Hank’s Balanced Salt Solution (HBSS) without 
Ca2+ and without Mg2+ (GIBCO). Finally, cover slips with the transfected neurons were put 
back in the original plates. After 2-4 days of incubation, cells were observed in an 
Olympus confocal microscope. 
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2.5 Confocal analysis of transfected neurons 
Image processing was performed in a Confocal Laser Scanning Biological 
Microscope (Olympus). Hippocampal neurons cultured in 25 mm diameter coverslips and 
transfected at DIV7, were located on a quartz slide and visualized in vivo. The images 
were captured using two channels (red and green) and a staking of several slices were 
taken per image. The table 2 and the figure 12 show the precise excitation values used for 
Kaede fluorescence emission detection. 
 
Table 3: Excitation light used to elicit Kaede green and red fluorescence.  
 
 
 
Figure 12: Spectra of green and red states of Kaede protein. 
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3. Results 
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3.1 Kaede plasmid modification 
Kaede protein is a fluorescent protein from a stony coral, Trachyphyllia geoffroyi, 
and it was cloned by Ando et al (2002). Kaede protein emits green, yellow and red light 
and includes a tripeptide, His-Tyr-Gly, that acts as a green chromophore that can be 
converted to red. The red fluorescence is comparable in intensity to the green 
fluorescence and is stable under usual aerobic conditions. Experiments proved that the 
green-red conversion is highly sensitive to irradiation with UV or violet light (350–400 nm), 
which excites the protonated form of the chromophore. The excitation lights used to elicit 
red and green fluorescence do not induce photoconversion (Ando et al., 2002). The 
pKaede-MC1 plasmid map used in this work is shown in the figure 13. 
 
Figure 13: Map of the plasmid pKaede MC1.  
Some restriction sites are shown and nucleotide sequence of each one is highligted by an asterisk (*). Kan/ 
Neo is the Kanamycin /Neomycin resistance gene for plasmid selection in E.coli. The nucleotide sequence of 
pKaede-MC1 is deposited in GenBank under the accession number AB085641. 
 
The comercial pKaede-MC1 plasmid is originally designed for expressing Kaede-
fusion proteins in eukaryotic cells. Thus, it lacks stop codons at the end of the Kaede 
coding sequence. To generate an improved version of the this pasmid to be used as a 
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local translation reporter, first step consisted in introducing a stop codon at the BamHI 
restrition site. 
In order to perform the plasmid linearization, the restrition enzime BamHI was 
used. As expected, only one fragment between 4,000 bp and 5,000 bp (~4,680 bp) was 
observed in the agarose gel after electrophoresis (Fig. 14).  
 
 
Figure 14: Restriction of pKaede plasmid with BamHI.  
A) After restriction with BamHI, an aliquot (1µl of dephosphorylated product) was visualized after 
electrophoresis. B) Preparative gel electrophoresis of approximately 5µg of linearized and dephosphorylated 
pKaede plasmid after extraction of DNA for subsequent purification.  
 
 
To insert a stop codon at the end of Kaede protein in pKaede-MC1, two 
complementary oligos named STOP-BamHI- fw and STOP-BamHI-rv were designed. 
These oligos were annealed and ligated to the BamHI-digested pKaede-MC1 plasmid. 
After E. coli transformation, six colonies were selected and analyzed. Insertion of the 
STOP-BamHI fragment was expected to originate new NheI and EcoRV sites (included in 
the STOP-BamHI oligos). Thus, to confirm oligo insertion, a restriction analysis using 
EcoRV was performed. The original pKaede sequence contains two EcoRV sites. As 
observed in figure 15, three main fragments of the expected size were obtained; one less-
intense band probably corresponding to a non-digested, supercoiled form of the 
corresponding plasmid was also appreciable, migrating at a position equivalent to 600 bp. 
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Figure 15: EcoRV restriction analysis of pKaede plasmid containing the STOP-BamHI fragment. 
Obtained bands between 5 kb and 4 kb, about 400 bp and 100 bp corresponded to the expected sizes. The 
less-intense band (600 bp) probably corresponded to a non-digested, supercoiled form. 
All the six hypothetical pKaede-3’UTR were sequenced. This confirmed the correct 
insertion of the STOP-BamHI oligos, the presence of the EcoRV restrition site and the 
regeneration of the BamHI site in one of the transformed colony (Fig. 16). 
 
Figure 16: Correct insertion of STOP-BamHI oligo in pKaede (pKaede-3’UTR).  
The red box and the green line highlight respectively, the STOP-BamHI-fw and the STOP-BamHI-rv annealed 
oligos. The correct insertion originated the EcoRV restriction site and the regeneration of BamHI restriction 
site. This graph was obtained using the free version of CLC Sequence Viewer program. 
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The introduction of a stop codon at the BamHI restriction site of pKaede MC1 
plasmid, resulted in the pKaede-3’UTR. Besides the EcoRV restriction analysis and the 
plasmid sequencing have confirmed the correct insertion of STOP-BamHI oligos in the 
BamHI-digested pKaede-MC1, the presence of a unique restriction site upstream Kaede 
coding sequence was also determinant to continue the pKaede MC1 modification. This 
modification consisted in introducing a myristoylation signal upstream Kaede protein, in 
order to limit the diffusional rate of the protein. 
NheI restriction analysis confirmed the presence of only one NheI restriction site 
which allowed us to perform pKaede-3’UTR linearization (Fig. 17).  
 
Figure 17: Restrition of pKaede-3’UTR plasmid with NheI. 
A) After restriction with NheI, an aliquot (1µl of dephosphorylated product) was visualized after 
electrophoresis. B) Preparative gel electrophoresis of approximately 5µg of linearized and dephosphorylated 
pKaede-3’UTR plasmid after extraction of DNA for subsequent purification. 
The linearized and dephosphorylated form of pKaede-3’UTR with NheI compatible 
ends was used for ligation with the annealed 5-UTR-myr-fw and 5-UTR-myr-rv designed 
oligos (Table 2). After E. coli transformation, six colonies were selected and analyzed 
(Figure 18). Insertion of annealed 5-UTR-myr oligos were expected to originate an extra 
EcoRV site, a Kozak sequence and a myristoylation signal in frame with Kaede protein. 
To confirm oligo insertion, an EcoRV restriction analysis was performed. As can be 
observed in the figure 18, in four of the transformed colonies (numbers 1, 2, 3 and 5) four 
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main fragments were observed (in addition to the non-digested 600bp-migrating form), 
suggesting that the 5’UTR-myr oligos were successfully inserted. In the other two colonies 
(numbers 4 and 6) a similar pattern to that of the pKaede-3’UTR plasmid was obtained, 
indicating that in this case the oligo containing the myristoyltion signal was not inserted. 
All the four hypothetical p5’UTR-myrKAEDE-3’UTR were sequenced but the 5-
UTR-myr oligos were inserted in the antisense orientation in all cases. 
 
Figure 18: EcoRV restriction analysis of pKaede-3’UTR plasmid for testing 5’UTR-myr fragment 
insertion. 
In the transformed colonies 1, 2, 3 and 5 four fragments are observed. In the other two colonies (4 and 6) 
three fragments are observed. 
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3.2 Generation of DSCAM local translation reporters based on Kaede plasmid  
3’UTR from DSCAM isoforms 1, 3, 4 and 5 were obtained by double digestion with 
BamHI and BglII of the corresponding pLucCassette plasmids (see Material and Methods 
2.2). The isolated DSCAM 3’UTR isoforms obtained using these two enzymes generate 
DNA fragments with BamHI compatible ends.  
 
 
Figure 19: Isolation of DSCAM 3’UTR isoforms from the corresponding pLucCassette vector. 
Restriction analysis performed to obtain the DSCAM isoforms 1, 3, 4 and 5 (DSCAM-isof1, DSCAM-isof3, 
DSCAM-isof4, DSCAM-isof5). A) The first restriction enzyme BamHI linearizes the plasmid. B) After the 
second digestion (BglII) two fragments are obtained. The fragment between 3000bp and 4000bp corresponds 
to the vector. The other one (extracted in the picture shown in panel B) corresponds to DSCAM-isof4 in this 
particular example. The succeeded purification of this fragment with about 600bp is confirmed as observed in 
panel C. 
 
 
 
The original pKaede plasmid linearized with BamHI and dephosphorylated was 
used for direct cloning of DSCAM 3’UTR isoforms. The modified pKaede, pKaede-3’UTR 
was not used to conduct these constructions because the desired modifications of the 
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plasmid (p5’UTR-myrKAEDE-3’UTR) were not achieved in time. As the matter of fact, at 
the beginning of the experiments we also wanted to know if the original plasmid Kaede 
together with the DSCAM isoforms were expressed in hippocampal neuron cultures. So, 
Kaede plasmid modification and cloning of DSCAM 3’UTR isoforms in the original Kaede 
plasmid were performed at the same time.  
To obtain pKaede-DSCAM-isoforms several attempts were made. The figure 20 
shows the corresponding inserts separated from pKaede after restriction analysis with 
EcoRI.  
 
Figure 20: Constructions of pKaede with the DSCAM isoforms 1, 3, 4, 5 confirmed by restriction with 
EcoRI.  
The bands located between 5kb and 4kb correspond to pKaede vector. The other bands are identified in the 
figure by the name of the corresponding DSCAM isoform (“D-isof” is an abbreviation of “DSCAM-isoform”). 
 
 
The correct (i.e., sense) orientation of these constructions was confirmed by 
sequencing (see Appendix), comparing the sequences with the original DSCAM isoforms 
1, 3, 4 and 5 (Fig. 21). 
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Figure 21: DSCAM isoforms 1, 3, 4 and 5 sequences.  
DSCAM-isof1 (D-isof1) has 115 nucleotides in length and contains one CPE motif (TTTACT). DSCAM-isof3 
(D-isof3) has 355 nucleotides in length and three CPE motifs (TTTACT, AGTTTTA, TTTTACT), DSCAM-isof4 
(D-isof4) has 632 nucleotides and four CPE motifs (TTTACT, AGTTTTA, TTTTACT, TTTTAAT). DSCAM-isof5 
(D-isof5) has 977 nucleotides and 5 CPE motifs (TTTACT, AGTTTTA, TTTTACT, TTTTAAT, TTTTATT). CPE 
motifs are marked with green lines. These isoforms are encoded in the same exon, and are originated by 
alternative polyadenylation. This graph was obtained using the free version of CLC Sequence Viewer 
program. 
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3.3 Preliminary visualization of DSCAM local translation using Kaede reporters  
Hippocampal neurons were firstly transfected with the original pKaede MC1 
plasmid to test protein expression and visualization in an epifluorescence microscope 
equipped for standard green and red fluorescence visualization. However, the excitation 
light to elicit green and red fluorescence in Kaede protein is very narrow, 508/518 and 
572/580 respectively. For this reason we decided to use confocal microscopy because in 
this case, the specific Kaede parameters can be finely chosen. Two days after 
transfection using the original Kaede vector and the modified Kaede-3’UTR plasmid, 
neurons were observed. Kaede protein was visualized in the entire neuron (cell body, 
dendrites and axons; not shown). The modified Kaede-3’UTR plasmid permitted the 
expression of Kaede protein in a similar granular pattern as pKaede MC1 (Fig. 22 A). To 
assess the morphology of these granules, zoom amplification was made. Round distinct 
forms could be distinguished (Fig. 22 B and C). These images were used as controls to 
compare the expression of Kaede-based 3’UTR DSCAM-isoforms. For this purpose, the 
image in panel A was designed as the reporter control (RC) when the expression occurs 
in the entire neuron. The image in panel C was defined as the reporter control zoom 
(RCZ) and was used for comparison with Kaede-DSCAM-isoforms when the expression 
was localized in neurites (i. e., dendrites or axons). 
 
 
  
Figure 22: Visualization of Kaede reporters. 
A) Kaede-3’UTR plasmid expression in a transfected neuron. Scale bar, 100 µm. B) and C) Zoom of different 
neurites of panel A. Scale bar, 10 µm. 
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To confirm that the fluorescence observed in experiments summarized in figure 22 
was originated by the expression of Kaede, the photoconversion capacity of the protein 
was assessed. As shown in figure 23 decreasing of green fluorescence and increasing of 
red fluorescence was observed when neurons were subjected to succesive pulses of UV 
light. 
 
 
Figure 23: Visualization of Kaede photoconversion.  
A) Initial image showing green and red fluorescence when pKaede-3’UTR plasmid was used for neuron 
transfection.  B) Neurons after a 10 sec UV pulse. C) Neurons after a 20 sec UV pulse. (Total UV pulse= 30 
sec).   
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To assess the impact of the different 3’UTR DSCAM isoforms on Kaede 
expression, we decided to transfect DIV7 hippocampal neurons with the corresponding 
plasmid. Phenotypes were analyzed 2 days later. 
Kaede-DSCAM-isof1 expression apparently occurred in dendrites (and maybe 
axons) but the expression in neuron cell body was not detected (Fig. 24).  
 
 
 
 
 
 
Figure 24: Kaede-DSCAM-isof1 expression.  
RC) Reporter Control where neuron cell body and dendrites were visualized. Scale bar,100 µm. A) Expression 
of Kaede-DSCAM-isof1 in dendrites (and maybe axon). Note that expression was not detected in neuron cell 
body. Scale bar, 50 µm. 
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Kaede-DSCAM-isof3 expression was observed in dendrites and neuron cell body 
(Fig. 25). After a 20 sec UV pulse protein photoconversion was confirmed (Fig. 25, B1 and 
B2).  
 
 
 
Figure 25: Kaede-DSCAM-isof3 expression.  
RC) Reporter Control (same as fig. 22 A) where neuron cell body and dendrites were visualized. B) 
Expression of Kaede-DSCAM-isof3 in dendrites and in cell body. Scale bar, 50 µm. B1) Green fluorescence 
detection after a 20 sec UV pulse. B2) Red fluorescence visualization after a 20 sec UV pulse. 
 
 
 
When Kaede-DSCAM-isof4 expression was analysed an aberrant morphology was 
visualized in all the transfected neurons (Fig. 26 and Fig. 27). In this case, a high Kaede 
expression that mainly occurred in neuron cell body was evident when compared with the 
expression of Kaede-DSCAM- isoforms 1, 3 and 5.  
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Figure 26: Kaede-DSCAM-isof4 expression.  
RC) Reporter Control (same as Fig. 22 A) where neuron cell body and dendrites were visualized. Scale bar 
100 µm. RCZ) Reporter Control Zoom (same as Fig. 22 C). Scale bar, 10 µm. C) Expression of Kaede-
DSCAM-isof4. No evident cell body seems to be labeled in this image, although neurite labeling can be 
appreciated. Scale bar, 50 µm. C1) Green fluorescence before UV pulse. C2) Red fluorescence was not 
detected before UV pulse. Ca) Magnification of a Kaede-positive granule from panel C. Scale bar 10 µm. Ca1) 
Green fluorescence detection after a 20 sec UV pulse. Ca2) Red fluorescence detection after a 20 sec UV 
pulse. 
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Figure 27: Kaede-DSCAM-isof4 expression (II).  
Aberrant neuron morphology produced by transfection of pKaede-DSCAM-isof4. D) Cell body can be 
distinguished in this image. Expression of Kaede-DSCAM-isof4 is not strong in dendrites or axons. Scale bar, 
50 µm. E) In this transfected neuron, cell body is strongly marked, and neuritis are also detected, although 
with less intensity. Scale bar, 100 µm. D1, E1) Detection of green fluorescence after a 20 sec UV pulse. D2, 
E2) Red fluorescence detection after a 20 sec UV pulse. 
 
 
While the expression of Kaede-DSCAM-isof4 appears to be higher in the neuronal 
cell body and weakly detectable in dendrites and axons, Kaede-DSCAM-isof5 is 
apparently expressed in neurites. Thus, transfected neurons with pKaede-DSCAM-isof5 
did not show expression in cell bodies, but presented a distinct morphological feature 
consisting in granules that delineated what seemed to be axons (Fig. 28).  
 LOCAL TRANSLATION OF CANDIDATE mRNAs FOR DOWN’S SYNDROME  
51 
  
Figure 28: Kaede-DSCAM-isof5 expression.  
RC) Reporter Control where neuron body cell and dendrites are visualized (same as Fig. 22 A). Scale bar, 100 
µm. RCZ) Reporter Control Zoom (same as Fig. 22 C). Scale bar, 10 µm. F) Expression of pKaede-DSCAM-
isof5 showing no cell body labeling; however, neurite labeling (probably an axon) is evident. Scale bar, 50 µm. 
Fa) Magnification from panel F. Fa1) Green fluorescence detection after a 20 sec UV pulse. Fa2) Red 
fluorescence detection after a 20 sec UV pulse 
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4. Discussion 
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In neurons certain mRNA transcripts are transported to dendrites for localized 
translation (Bramham and Wells, 2007). In the last years, one of the greatest challenges 
in local translation studies are the identification of mRNA localization and protein 
synthesis within discrete cell compartments (Martin and Ephrussi, 2009). We have 
described the visualization of DSCAM synthesis in postnatal hippocampal neurons, using 
the photoconvertible Kaede reporter protein. 
 
The first visualization method that provided the initial evidence that dendrites are 
capable of autonomous translational control occurred by using transmission electron 
microscopy (TEM). Owing to its unique ability to resolve the fine intracellular structure of 
neurons, it has remained an important tool for understanding local protein synthesis in 
dendrites and its relationship to synaptic plasticity and memory (Ostroff et al., 2002). In a 
recent study using this technique, it has been demonstrated that fear conditioning 
increases both the number of dendritic polyribosomes and their association with the spine 
apparatus in lateral amygdala neurons. The observed increase in polyribosomes likely 
reflects an overall increase in dendritic translation after fear learning, although other 
interpretations cannot be fully ruled out (Ostroff et al., 2010). The major limitation of TEM 
is that changes in dendritic translation relative to baseline cannot be studied in the same 
sample. This deficiency prompted the development of methods to dynamically visualize 
local synthesis of proteins in neuronal processes. The first tools developed used a 
myristoylated green fluorescent protein (GFP) (Aakalu et al., 2001). This myristoylation 
signal provides an excellent advantage by allowing the reporter to attach the membrane, 
avoiding the protein diffusion through the whole cell. However, photobleaching is 
necessary for eliminating the signal from pre-existing GFP protein, as this technique is 
based in fluorescence after photobleaching (FRAP), and this may be toxic for the cells.  
The recovery of GFP fluorescence in dendrites following photobleaching is due to both 
diffusion from the adjacent (nonbleached) compartment as well as the new synthesis of 
the reporter in the bleached domain (Aakalu et al., 2001). This can lead to the 
visualization of increased fluorescence that does not reflect the real protein expression. 
Furthermore, there are FRAP experiment that describe that the rate of degradation of the 
reporter can exceeded the rate of diffusion of the reporter (Aakalu et al., 2001). This can 
lead to decreased fluorescence capture. Attending to this, the use of GFP in local 
translation experiments do not provide a mean to obtain trustable and clear results about 
new local protein expression.  
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In the present work, the Kaede-MC1 plasmid that encodes the photoconvertible 
fluorescent protein Kaede was used. It provides a mean of monitoring new local 
translation because all preexisting protein can be photoconverted from green to red, and 
then  new translation can be monitored as the appearance of new green signal (Ando et 
al., 2002). Despite this ability, only the expression of Kaede and Kaede-DSCAM-isoforms 
in hippocampal neuron cultures was assessed here.  
 
The preliminary results shown in this work represent a first approach to identify in 
which compartments of a single neuron DSCAM isoforms are expressed. Studies 
performed on the same isoforms, reported that isoforms 1, 3, and 5 appeared to be more 
abundant in the neonatal hippocampus than in adult tissues, suggesting their role in 
developmental processes. In what concerns to isoform 4 in P0 and adult tissues, similar 
levels of expression were found, suggesting that this isoform may play a predominant role 
in neuronal physiology (Alves-Sampaio et al., 2010). Attending to the documented 
expression of these four DSCAM isoforms in neonatal hippocampus, all of them were 
expected to be expressed in this experimental approach. The next table summarizes the 
localized compartments where the expression of the different constructions in single 
neurons was observed. Due to the difficulty for distinguish some neuronal cell 
compartments, all the fluorescence observed in continuous or discontinuous points 
(granules), were assumed to be dendrites and/or axons. 
Table 4: Localization overview of Kaede and Kaede-DSCAM-isoforms expression. 
Reporter/ DNA constructions Neuronal Compartment 
Cell body Dendrites/ Axons 
Kaede  √ √ 
Kaede-3’UTR √ √ 
Kaede-DSCAM-isof1 ─ √ 
Kaede-DSCAM-isof3 √ √ 
Kaede-DSCAM-isof4 √ ─ 
Kaede-DSCAM-isof5 ─ √ 
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Kaede-DSCAM-isof1 expression apparently occurred in dendrites or axon but the 
expression in neuron cell body was not identified. The same happened with Kaede-
DSCAM-isof5. However, the morphology of the Kaede granules seemed to be different in 
both cases. Thus, whereas granules were large and oval-shaped in the case of Kaede-
DSCAM-isof5, they were round and small in the case of Kaede-DSCAM-isof1. This 
suggests that these isoforms may be transported from the soma in RNA granules and 
regulated translation may occur by different mechanisms during the transport. For 
instance, in the case of mammalian Staufen proteins, there is biochemical evidence that 
some RNA granules contain ribosomes, whereas others do not. When fractionated by 
size, the largest Staufen pools contained ribosomal and endoplasmic reticulum (ER) 
markers, whereas the smaller RNA granules were free of ribosomes and ER but 
cofractionated with conventional kinesin (Mallardo et al., 2003). Furthermore, it is 
assumed that during transport mRNAs might be translationally repressed within granules 
but studies also report that mRNAs can be released from the granules, and/or be 
derepressed in response to neuronal activity, allowing for local translation (Krichevsky and 
Kosik, 2001, Huttelmaier et al., 2005).  
Kaede-DSCAM-isof3 expression was observed in dendrites and neuron cell body. 
This suggests that the translation of this isoform may be regulated by several 
mechanisms. First, after Kaede-DSCAM-isof3 translation in the soma, the new 
synthetized protein may be transported to the dendrites. Second, mRNA may be 
transported from the soma to the dendrites and being translated in this way, leaving a 
footprint in form of synthetized protein. Finally, due to the similarity of expression between 
Kaede and Kaede-DSCAM-isof3, the possibility of having problems with the plasmid that 
may lead to DSCAM-isof3 incorrect translation, have to be taken in count.    
In the case of kaede-DSCAM-isof4 an aberrant morphology was visualized. In this 
case, high Kaede expression occurred in neuron cell body when compared with the 
expression of Kaede-DSCAM-isoforms 1, 3 or 5. The overexpression appears to confer a 
kind of apoptotic neuronal feature. DSCAM-isof4 contains four CPE motifs (TTTACT, 
AGTTTTA, TTTTACT, TTTTAAT) that are expected to be recognized by CPEB proteins. 
Interestingly, recent works have shown that CPEB also coordinates the translation 
regulation of p53 mRNA  (Richter et al., 2011) a tumor suppressor and transcription factor 
that is a key modulator of cellular stress responses (Culmsee and Mattson, 2005). 
Besides polyadenylation sites, CPEB 3' UTR contains two miR-122 binding sites, which 
when deleted, elevate mRNA translation. Although miR-122 is thought to be liver specific, 
it is present in primary fibroblasts and destabilized by Gld2 depletion. Gld4, a second non-
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canonical poly(A) polymerase, was found to regulate p53 mRNA 
polyadenylation/translation in a CPEB-dependent manner. Thus, translational regulation 
of p53 mRNA and cellular senescence is coordinated by Gld2/miR-122/CPEB/Gld4 
(Richter et al., 2011). Activation of p53 can trigger apoptosis in many cell types including 
neurons (Culmsee and Mattson, 2005). This suggest that CPEB controls senescence and 
bioenergetics in human cells at least in part by modulating p53 mRNA polyadenylation-
induced translation (Richter and Burns, 2008) and, attending to the results, expression of 
DSCAM-isof4 may trigger this activation. However, improvements of the experiment 
should be made to obtain more reliable and consistent results. 
 
Some of these improvements imply Kaede plasmid modification. The Kaede 
plasmid used to insert DSCAM isoforms 1, 3, 4 and 5 do not have stop codons. This could 
have led to altered protein conformation and the absence of Kaede fluorescence after 
synthesis. However, as demonstrated in the point 3.3 of this work, photoconversion 
occurs after a 20sec UV pulse, confirming that the His-Tyr-Gly chromophore did not 
suffered modifications. Even so, in the plasmid Kaede-3’UTR, a myristoylation signal that 
inhibits the free diffusion of the reporter (Aakalu et al., 2001) should be added. 
Furthermore, a polylinker at the 5’ UTR of Kaede protein could also be added allowing the 
possibility of cloning the 5’UTR of DSCAM isoforms that may also contain DTEs and other 
regulatory sequences. Due to the polyadenylation signals of DSCAM are in tandem, 
DSCAM-isoform 5 plasmid can also produce the 3’UTR of DSCAM Isoforms 1, 3 and 4. 
This could be overtaken by constructing synthetic mRNAs and instead of transfection, 
another method like microinjection of mRNA-based reporters could be used.   
 
mRNAs that are important for LTP might be a different or overlapping population 
from those that are required for LTD, but both are presumably present in the same region 
of the dendrite (Bramham and Wells, 2007). The remaining question is how selective 
mRNAs are activated while others remain dormant. The answer might reside in the 
presence of RNA-binding proteins (ZBP1, CPEB and FMRP) that bind to specific cis-
elements (DTEs) and are capable of regulating mRNA translation. One example of this 
type of regulation is the regulation of β-actin mRNA by ZBP1. Studies performed in 
chicken, reported that ZBP1 modulates the translation of b-actin mRNA. ZBP1 associates 
with the b-actin transcript in the nucleus and prevents premature translation in the 
cytoplasm by blocking translation initiation. Translation only occurs when the ZBP1–RNA 
complex reaches its destination at the periphery of the cell. At the endpoint of mRNA 
 LOCAL TRANSLATION OF CANDIDATE mRNAs FOR DOWN’S SYNDROME  
59 
transport, the protein kinase Src promotes translation by phosphorylating a key tyrosine 
residue in ZBP1 that is required for binding to RNA (Huttelmaier et al., 2005).  The 
dynamic movements of ZPB1 in response to KCl-induced depolarization at high spatial 
and temporal resolution (Tiruchinapalli et al., 2003) also implicate RNA binding proteins as 
regulators of mRNA transport to activated synapses in response to synaptic activity.  So, 
for obtaining more clues about the regulation of DSCAM by RNA-binding proteins, neuron 
stimulation should be performed and live visualization of DSCAM expression could be 
monitored.  
 
The application of the methodology described in this work with the suggested 
improvements in Ts1Cje or Ts65Dn trissomic mice, may lead to more precise results 
about the role of DSCAM in DS. 
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5. Conclusion and perspectives 
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In conclusion, the four different isoforms have distinct expression locations in 
neurons. Kaede-DSCAM-isof1 is expressed in neurites (dendrites and axons) but not in 
cell body whereas Kaede-DSCAM-isof3 appears to be expressed in both compartments. 
Kaede-DSCAM-isof4 expression appears to confer a rare morphological feature to neuron 
cell body were it is highly expressed. Expression of Kaede-DSCAM-isof5 is visualized in 
oval granules continuously connected in what appears to be an axon. The results 
presented in this work with hippocampal neurons shows that DSCAM isoform 1 may be 
repressed at the soma, DSCAM isoform 3 appear not to be specifically regulated and 
isoforms 4 and 5 appear to be repressed and activated (strong activated in case of 
isoform 4 and weakly activated in case of isoform 5). So, the regulation of isoforms 4 and 
5 fitted the CPE code unlike the predicted behaviour for DSCAM isoforms 1 and 3.  
Although synaptic stimulation was not performed in this work, the use of Kaede as 
a local translation reporter, represents a reliable strategy for visualize DSCAM local 
expression in hippocampal neuron cultures. However, some improvements that imply 
Kaede plasmid modification should be performed., A myristoylation signal that inhibits the 
free diffusion of the reporter (Aakalu et al., 2001) should be added to the plasmid Kaede-
3’UTR obtained in this work. Furthermore, a polylinker at the 5’ UTR of Kaede protein 
could also be added allowing the possibility of cloning the 5’UTR of DSCAM isoforms that 
may also contain DTEs and other regulatory sequences. So, for obtaining even more 
clues about the regulation of DSCAM by RNA-binding proteins, neuron stimulation should 
be performed and live visualization of DSCAM isoforms expression could be monitored.  
The application of the methodology described in this work with the suggested 
improvements in Ts1Cje or Ts65Dn trissomic mice, may also lead to more precise and 
valuable results about the role of DSCAM in DS. 
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Alignment of DSCAM isoform 1 sequence with the constructed Kaede-DSCAM-isoform 1. 
 
Alignment of DSCAM isoform 3 sequence with the constructed Kaede-DSCAM-isoform 3.  
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Alignment of DSCAM isoform 4 sequence with the constructed Kaede-DSCAM-isoform 4.  
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Alignment of DSCAM isoform 5 sequence with the constructed Kaede-DSCAM-isoform 5.  
 
